Notably, MCF7A4−CRISPR cells appeared to compensate from lack of ANXA4 by upregulating their ANXA6 protein expression, suggesting that MCF7 cancer cells require at least one of these proteins to counteract plasma membrane damage (Fig. 6b). This evidence concerns the gene ANXA6 and cancer.